SCHEMBL2011913

SCHEMBL2011913

CN(C(=O)c1ccc2[nH]ccc2c1)[C@@H](CCCNC(=O)c1cccn1C)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.45
HCRTR2 O43614 1/20 0.45
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
HDAC1 Q13547 4/20 0.40
HDAC2 Q92769 3/20 0.40
HDAC3 O15379 3/20 0.40
HDAC4 P56524 2/20 0.40
HDAC7 Q8WUI4 2/20 0.40
HDAC10 Q969S8 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
HDAC5 Q9UQL6 2/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
NAMPT P43490 2/20 0.39
CTNNB1 P35222 1/20 0.37
WNT3A P56704 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2011909 1.00 HCRTR1 (0.45) HCRTR1HCRTR2NPC1RAB9AHDAC1
SCHEMBL2012515 0.83 HCRTR1 (0.65) HCRTR1HCRTR2NPC1RAB9AHDAC1
SCHEMBL2014754 0.83 HCRTR1 (0.46) HCRTR1HCRTR2NPC1RAB9ANAMPT
SCHEMBL2014753 0.83 HCRTR1 (0.46) HCRTR1HCRTR2NPC1RAB9ANAMPT
SCHEMBL2016048 0.81 HCRTR1 (0.46) HCRTR1HCRTR2NPC1RAB9AHDAC1
SCHEMBL2016049 0.81 HCRTR1 (0.46) HCRTR1HCRTR2NPC1RAB9AHDAC1
SCHEMBL2054156 0.73 NPC1 (0.41) HCRTR1HCRTR2NPC1RAB9AADRA1D
SCHEMBL2012583 0.70 HCRTR1 (0.64) HCRTR1HCRTR2NPC1RAB9ACTNNB1
SCHEMBL2010943 0.69 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9AHDAC1
SCHEMBL2014120 0.68 HCRTR1 (0.68) HCRTR1HCRTR2NPC1RAB9AHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed